Moderna ( MRNA )—most shorted—saw short interest rise to 10.02% from 9.14% in September. Cencora ( COR) came in second with a ...

BDX boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of Becton Dickinson are trading at a forward earnings multiple of 15.8X, as well as a PEG Ratio ...

Key Insights The projected fair value for Becton Dickinson is US$330 based on 2 Stage Free Cash Flow to Equity ...

Axxcess Wealth Management LLC raised its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% in the ...

Partnership signed on the sidelines of Global Health Saudi 2024; aims to drive patient safety, reduce medication errors, and ...

Capital Performance Advisors LLP bought a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) in ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares opened today at $226.95. Wise covers ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price target of $275.00. The company’s shares closed ...

BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 ...